Oral health care pathways for patients with epidermolysis bullosa: A position statement from the European reference network for rare skin diseases [0.03%]
关于罕见皮肤病欧洲参考网络的表皮松解症患者的口腔保健路径声明
S Krämer,A L Hillebrecht,K Bekes et al.
S Krämer et al.
Background: Inherited epidermolysis bullosa (EB) comprises a group of genetic disorders characterized by skin fragility and unique oral features. It requires interdisciplinary care from several health professionals, inclu...
Epidemiology and treatment of Adamantiades-Behçet's disease in Germany: A healthcare claims database study [0.03%]
德国阿达马尼迪斯-贝赫切特病的流行病学和治疗：医疗索赔数据库研究
C C Zouboulis,J Borchert,J Diesing et al.
C C Zouboulis et al.
Background: Adamantiades-Behçet's disease (ABD) is a rare, chronic, relapsing, multisystem vasculitis, with a reported prevalence of 0.9 out of 100,000 population in Germany in 2012. However, more recent epidemiological ...
Long-term real costs of a strategy using rituximab as first-line treatment for patients with moderate-to-severe pemphigus: Evaluation from the French healthcare system [0.03%]
利妥昔单抗作为治疗中重度天疱疮一线药物的长期真实成本：从法国医疗保障体系进行评估
Billal Tedbirt,Hermance De Mulder,Pascal Joly et al.
Billal Tedbirt et al.
Infections and genotypes of Chlamydia trachomatis among men who have sex with men in China: A nationwide community-based study [0.03%]
中国男男性行为人群沙眼衣原体感染及基因型全国社区队列研究
Ting-Ting Jiang,Ning-Xiao Cao,Wan-Yue Zhang et al.
Ting-Ting Jiang et al.
Long-term follow-up of a randomized, double-blind, phase III, multi-centre study to evaluate the safety and efficacy of field-directed photodynamic therapy (PDT) of mild to moderate actinic keratosis using BF-200 ALA versus placebo and the BF-RhodoLED® lamp [0.03%]
BF-200ALA联合BF-RhodolED灯进行光动力治疗轻中度光化性角化病随机双盲多中心III期临床试验的长期随访研究：安全性和有效性的评估
U Reinhold,W G Philipp-Dormston,T Dirschka et al.
U Reinhold et al.
Background: In actinic keratosis (AK), field cancerization describes areas of skin where multiple visible AK lesions are surrounded by healthy looking skin containing non-visible (subclinical) lesions. As all AK lesions h...
The association of Hidradenitis Suppurativa with comorbidities in underrepresented patient populations: An All of Us database analysis [0.03%]
“罕见人群中汗腺炎与合并症的关联：来自All of Us研究计划数据库的分析”
Katie Roster,Lauren Fleshner,Banu Farabi et al.
Katie Roster et al.
Dermatological societies and their climate change and sustainability commitment through 2024 [0.03%]
皮肤病学协会通过2024年之前在气候变化和可持续性方面的承诺
Dennis Niebel,Simon Tso,Eva Rawlings Parker et al.
Dennis Niebel et al.
Quantifying time to medical and/or surgical therapy after diagnosis of hidradenitis suppurativa and pilonidal sinus disease: A propensity-matched real-world cohort analysis [0.03%]
量化汗腺炎和坐骨窦疾病诊断后接受医疗和/或外科治疗的时间：一项倾向匹配的真实世界队列分析
Tara Sholji,Raaisa Islam,James Pham et al.
Tara Sholji et al.
Systemic anti-inflammatory therapy in congenital ichthyosis: Real-world experience in a series of 22 cases [0.03%]
先天性鱼鳞病的全身抗炎治疗：22例系列的真实世界经验
Laura Katharina Trefzer,Miodrag Davidovic,Donglin Li et al.
Laura Katharina Trefzer et al.